학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 208건 | 목록 1~20
Academic Journal
Fernández-Garnacho EM; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Martínez-Muñoz C; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Nadeu F; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Clot G; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Valero JG; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Araujo-Ayala F; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Martínez-Farran A; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; De Bolòs A; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Colomer D; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Mozas P; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Rivero A; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Giné E; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; López-Guillermo A; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Salaverria I; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; López C; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Beà S; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Amador V; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Demajo S; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Jares P; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Martín-Subero JI; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Pérez-Galán P; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Campo E; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Hernández L; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. hernan@recerca.clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. hernan@recerca.clinic.cat.; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, Barcelona, 08036, Spain. hernan@recerca.clinic.cat.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Nylund P; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Garrido-Zabala B; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Tziola SI; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Mohajershojai T; Department of Medicine, Karolinska Institute, Stockholm, Sweden.; Berglund H; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Muylaert C; Department of Hematology and Immunology, Translational Oncology Research Center, Vrije Universiteit Brussel, Brussels, Belgium.; Van Hemelrijck LA; Department of Hematology and Immunology, Translational Oncology Research Center, Vrije Universiteit Brussel, Brussels, Belgium.; Atienza Párraga A; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Vasquez L; Department of Laboratory Medicine, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Lund, Sweden.; Jacob J; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Bergquist E; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Martín-Subero JI; Hematopathology Section, Department of Pathology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Öberg F; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Karlsson T; Division of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Nestor M; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; De Bruyne E; Department of Hematology and Immunology, Translational Oncology Research Center, Vrije Universiteit Brussel, Brussels, Belgium.; Kalushkova A; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Wiklund HJ; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Planell N; Centro de Investigación Médica Aplicada (CIMA), Computational Biology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad de Navarra, Pamplona, Spain.; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Martínez-de-Morentin X; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Mouzo D; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Lara-Astiaso D; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Vilas-Zornoza A; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Martín-Uriz PS; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Alignani D; Flow Cytometry Core Facility, Centro de Investigación Médica Aplicada, CCUN, IdiSNA, CIBERONC, Universidad de Navarra, Pamplona, Spain.; Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, CCUN, IdiSNA, CIBERONC, Universidad de Navarra, Pamplona, Spain.; Maillo A; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Kurowska A; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Berastegui N; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Garcia-Olloqui P; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Urdangarin A; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Noori P; Translational Cardiology, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.; Ortega-Legarreta A; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Hernaez M; Centro de Investigación Médica Aplicada (CIMA), Computational Biology Program, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad de Navarra, Pamplona, Spain.; Lagani V; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; SDAIA-KAUST Center of Excellence in Data Science and Artificial Intelligence, Thuwal 23952, Saudi Arabia.; Institute of Chemical Biology, Ilia State University, Tbilisi 0162, Georgia.; Kiani N; Department of Oncology-Pathology, Center of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Algorithmic Dynamics Lab, Center of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Merkenschlager M; MRC LMS, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.; Ezponda T; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Ramírez RN; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.; Tegner J; Computer, Electrical, and Mathematical Sciences and Engineering Division (CEMSE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Bioengineering Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.; Unit of Computational Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, L8:05, SE-171 76 Stockholm, Sweden.; Science for Life Laboratory, Tomtebodavagen 23A, SE-17165 Solna, Sweden.; Prosper F; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Hematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain.; Gomez-Cabrero D; Translational Bioinformatics Unit, Navarrabiomed, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal 23955, Saudi Arabia.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Academic Journal
Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. nadeu@recerca.clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. nadeu@recerca.clinic.cat.; Shuai S; Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.; Clot G; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hilton LK; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Diaz-Navarro A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.; Martín S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Royo R; Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Baumann T; Hospital Clínic of Barcelona, Barcelona, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain.; Kulis M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; López-Oreja I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Cossio M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Lu J; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Young E; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Plevova K; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Knisbacher BA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.; Lin Z; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard University, Cambridge, MA, USA.; Hahn CK; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bousquets P; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.; Alcoceba M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Biología Molecular e Histocompatibilidad, IBSAL-Hospital Universitario, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; González M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Biología Molecular e Histocompatibilidad, IBSAL-Hospital Universitario, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; Colado E; Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias; Instituto Universitario de Oncología del Principado de Asturias (IUOPA); and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Payer ÁR; Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias; Instituto Universitario de Oncología del Principado de Asturias (IUOPA); and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Aymerich M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Terol MJ; Servicio de Hematología, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia, Valencia, Spain.; Rivas-Delgado A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Enjuanes A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Ruiz-Gaspà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Chatzikonstantinou T; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.; Hägerstrand D; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Stranska K; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Doubek M; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; van Gastel-Mol EJ; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.; Davis Z; Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, UK.; Walewska R; Department of Haematology, University Hospitals Dorset, Bournemouth, UK.; Scarfò L; Università Vita Salute San Raffaele, Milano, Italy.; Strategic Research Program on CLL, IRCCS San Raffaele Hospital, Milano, Italy.; Trentin L; Department of Medicine, Hematology unit, University of Padua, Padua, Italy.; Visentin A; Department of Medicine, Hematology unit, University of Padua, Padua, Italy.; Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Rabe KG; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.; Moia R; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.; Armand M; Department of Laboratory Medicine and Pathology, Hospital Pitie-Salpetriere, Sorbonne University, Paris, France.; Rossi D; Department of Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.; Davi F; Department of Laboratory Medicine and Pathology, Hospital Pitie-Salpetriere, Sorbonne University, Paris, France.; Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.; Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Shanafelt TD; Stanford School of Medicine, Stanford, CA, USA.; Ghia P; Università Vita Salute San Raffaele, Milano, Italy.; Strategic Research Program on CLL, IRCCS San Raffaele Hospital, Milano, Italy.; Oscier D; Department of Haematology, University Hospitals Dorset, Bournemouth, UK.; Langerak AW; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.; Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; López-Guillermo A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Getz G; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Pospisilova S; Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.; Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.; Stein LD; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.; Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.; Puente XS; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.; Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ecampo@clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. ecampo@clinic.cat.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. ecampo@clinic.cat.; Hospital Clínic of Barcelona, Barcelona, Spain. ecampo@clinic.cat.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
CLINICAL CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Academic Journal
EPIGENOMICS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Fundació Sant Joan de Déu
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Academic Journal
Gómez-Echarte N; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra.; José-Enériz ES; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid.; Carrasco-León A; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid.; Barrena N; Universidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País Vasco.; Miranda E; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid.; Garate L; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, Navarra.; García-Torre B; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.; Alonso-Moreno S; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain; Catalan Institute of Oncology (ICO), Cancer Therapeutic Resistance Program (ProCURE), Badalona, Barcelona.; Gimenez-Camino N; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra.; Urizar-Compains E; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra.; Olaverri-Mendizabal D; Universidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País Vasco.; Aguirre-Ruiz P; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra. xaguirre@unav.es.; Ariceta B; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra.; Tamariz-Amador LE; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, Navarra.; Rodriguez-Otero P; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, Navarra.; Planes FJ; Universidad de Navarra, Tecnun Escuela de Ingeniería, San Sebastián, País Vasco.; Belver L; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain; Catalan Institute of Oncology (ICO), Cancer Therapeutic Resistance Program (ProCURE), Badalona, Barcelona.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona.; Prosper F; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Servicio de Hematología y Terapia Celular, Clínica Universidad de Navarra (CUN), Pamplona, Navarra. fprosper@unav.es.; Agirre X; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarra, Spain; Cancer Centre Clínica Universidad de Navarra (CCUN), Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Academic Journal
Ustaszewski A; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.; Paczkowska J; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.; Janiszewska J; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.; Bernhart SH; Interdisciplinary Center for Bioinformatics, Transcriptome Bioinformatics, University of Leipzig, Leipzig, Germany.; Bein J; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Russiñol N; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.; Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute of General Pharmacology and Toxicology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Chapaprieta V; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Facultat de Medicina, Hospital Clínic de Barcelona and Departament de Fonaments Clínics, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, ICREA, Barcelona, Spain.; Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.; Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Giefing M; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Vila-Pueyo M; Headache and Neurological Pain Research Group, Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.; Pediatric Neurology Research Group, Vall Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.; Cuenca-León E; Headache and Neurological Pain Research Group, Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.; Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, Spain.; Queirós AC; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Spain.; Kulis M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Spain.; Sintas C; Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, Spain.; Cormand B; Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Pozo-Rosich P; Headache and Neurological Pain Research Group, Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.; Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Fernàndez-Castillo N; Departament de Genètica, Facultat de Biologia, Universitat de Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Spain.; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.; Macaya A; Pediatric Neurology Research Group, Vall Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.; Institute of Neuroscience, Universitat Autònoma de Barcelona, Barcelona Spain.
Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE
Academic Journal
Charalampopoulou S; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Chapiro E; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France.; Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zürich, Zurich, Switzerland.; Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Martínez-Farran A; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Aymerich M; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Rozman M; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Roos-Weil D; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France.; Bernard O; Gustave Roussy, INSERN U1170, Villejuif, France.; Susin SA; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France.; Parker H; Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Walewska R; Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom.; Oakes CC; Division of Hematology, The Ohio State University, Columbus, OH.; Strefford JC; Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Matutes E; Pathology Department, Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain.; Duran-Ferrer M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Nguyen-Khac F; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Dupéré-Richer D; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Riva A; Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL.; Barwick BG; Department of Hematology and Medical Oncology, School of Medicine, Emory University, Winship Cancer Institute, Atlanta, GA.; Maji S; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Casellas Román H; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL.; Li J; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; De U; Department of Pathology, Immunology and Laboratory Medicine, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Sobh A; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Quickstad G; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Piper C; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Kulis M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.; Ezponda T; Hemato-Oncology Department, Cima Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Departamento de Fundamentos Clínicos, Universitat de Barcelona, Barcelona, Spain.; Tonon G; Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milano, Italy.; Zhang W; Department of Pathology, Immunology and Laboratory Medicine, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Boise LH; Department of Hematology and Medical Oncology, School of Medicine, Emory University, Winship Cancer Institute, Atlanta, GA.; Bennett RL; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.; Licht JD; Division of Hematology/Oncology, University of Florida Health Cancer Center, University of Florida, Gainesville, FL.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Pérez RF; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Jiménez-Martínez V; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. imartins@recerca.clinic.cat.; University of Barcelona, Barcelona, Spain. imartins@recerca.clinic.cat.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. imartins@recerca.clinic.cat.
Publisher: Nature Publishing Group US Country of Publication: United States NLM ID: 101773306 Publication Model: Print Cited Medium: Internet ISSN: 2662-8465 (Electronic) Linking ISSN: 26628465 NLM ISO Abbreviation: Nat Aging Subsets: MEDLINE; In Process
검색 결과 제한하기
제한된 항목
[검색어] Martín-Subero JI
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어